Prot #I4V-MC-JAIW: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe Atopic Dermatitis

  • Silverberg, Jonathan I (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/12/18 → 1/28/20

Funding

  • Lilly USA, LLC (Prot #I4V-MC-JAIW)